E-resources
PDF-
Venturini, Elisabetta; Montagnani, Carlotta; Garazzino, Silvia; Donà, Daniele; Pierantoni, Luca; Lo Vecchio, Andrea; Krzysztofiak, Andrzej; Nicolini, Giangiacomo; Bianchini, Sonia; Galli, Luisa; Villani, Alberto; Gattinara, Guido Castelli
Italian journal of pediatrics, 10/2021, Volume: 47, Issue: 1Journal Article
...the available literature on pediatric treatment strategies for SARS-CoV-2 infection in children was reviewed up to 10 March 2021 on PubMed, the website of national and international scientific societies and of clinical trials. In particular, for the age group 12–17 years, the risk factors are the following: body mass index > 95 percentile for age, sickle cell anemia, congenital or acquired cardiac disease, neurodevelopment disease, device carriers (tracheostomy, gastrostomy, etc.), asthma or other respiratory disorders requiring daily treatment 17, 18. ...the best treatment for pediatric COVID-19 is currently not well defined, because randomized trials in children are lacking.
